2026.01.21
Japan Advances Regulatory Reforms on RWD Utilization, Conditional Approval, and Pediatric Drug Development
Introduction to Regulatory Revisions According to the notification issued by Japan’s Ministry of Health, Labou […]
2025.09.17
PMDA Symposium 2025: Key Takeaways for Pediatric Drug Development
IntroductionOn August 27, 2025, the PMDA hosted a symposium titled “Toward Enhanced Pediatric Pharmacotherapy […]
2025.01.21
Japan’s Upcoming Amendments to the Pharmaceutical and Medical Device Act
Japanese Pharmaceutical and Medical Device Act revisions aim to establish a pharmaceutical industry that ensures stable and reliable access to medicines for the public.